PPH 株価推移チャート
PPH 株価予測
VanEck Pharmaceutical ETF
戻る
VanEck Pharmaceutical ETF (PPH) 株価予測
According to analyst forecasts, we anticipate notable price fluctuations for PPH in the upcoming periods. Looking toward the future, our 2026 projection indicates an average price target of $116.07. The lowest target is $91.06 and the highest is $143.89. Empower your investment choices with our cutting-edge, data-driven analysis!
PPH 株価予測の概要
PPHを買うべきですか？
PPHのトップアナリスト評価
24人のアナリストによる PPHの株式レートに基づき、Oct 01, 2025に更新されました。
Strong buy
8
Buy
9
Hold
6
Sell
1
Strong sell
0
Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for PPH. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: PPH is a Buy candidate.
PPH stock price ended at $110.63 on 木曜日, after rising 0.69%
On the latest trading day Aug 06, 2026, the stock price of PPH rose by 0.69%, climbing from $111.65 to $110.63. Throughout the session, the stock experienced a volatility of 2.57%, with prices fluctuating between a daily low of $109.60 and a high of $112.42. Alongside this price increase, trading volume also rose by 376.2K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 147.6K shares were traded, amounting to a market value of approximately $943.6M.
PPH テクニカルシグナル
テクニカルシグナルの概要
Strong Sell
Sell
Neutral
Buy
Strong Buy
PPHは現在、3個の買いシグナルと2個の売りシグナルを表示しています。この銘柄は12:00 AM以来上昇トレンドの状態にあり、この期間に価格は合計2.29%変動しました。全体として、テクニカル指標は中期的な見通しがBuyであることを示しています。
PPHの強気／弱気シグナル
当社のアルゴリズムは、移動平均線、RSI、MACD、取引高などの主要な指標を分析し、PPHの強気および弱気シグナルを生成します。これらの暗号通貨の洞察は、賢明な投資決定を下すのに役立ちます。
主要データ
前終値
$109.87
始値
$111.65
当日レンジ
$109.6 - $112.42
52週レンジ
$81.74 - $114.57
取引高
147.2K
平均取引高
272.7K
配当利回り
1.76%
純資産
$0
NAV
--
費用率
--
発行済株式数
8.5M
PPHとは何ですか？
PPH was created on 2011-12-20 by VanEck. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 960.98m in AUM and 26 holdings. PPH tracks a market-cap-weighted index of 25 of the largest global pharmaceutical firms.
